Literature DB >> 23172692

Disease risk score as a confounder summary method: systematic review and recommendations.

Mina Tadrous1, Joshua J Gagne, Til Stürmer, Suzanne M Cadarette.   

Abstract

PURPOSE: To systematically examine trends and applications of the disease risk score (DRS) as a confounder summary method.
METHODS: We completed a systematic search of MEDLINE and Web of Science® to identify all English language articles that applied DRS methods. We tabulated the number of publications by year and type (empirical application, methodological contribution, or review paper) and summarized methods used in empirical applications overall and by publication year (<2000, ≥2000).
RESULTS: Of 714 unique articles identified, 97 examined DRS methods and 86 were empirical applications. We observed a bimodal distribution in the number of publications over time, with a peak 1979-1980, and resurgence since 2000. The majority of applications with methodological detail derived DRS using logistic regression (47%), used DRS as a categorical variable in regression (93%), and applied DRS in a non-experimental cohort (47%) or case-control (42%) study. Few studies examined effect modification by outcome risk (23%).
CONCLUSION: Use of DRS methods has increased yet remains low. Comparative effectiveness research may benefit from more DRS applications, particularly to examine effect modification by outcome risk. Standardized terminology may facilitate identification, application, and comprehension of DRS methods. More research is needed to support the application of DRS methods, particularly in case-control studies.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23172692      PMCID: PMC3691557          DOI: 10.1002/pds.3377

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  112 in total

1.  Processes of care associated with acute stroke outcomes.

Authors:  Dawn M Bravata; Carolyn K Wells; Albert C Lo; Steven E Nadeau; Jean Melillo; Diane Chodkowski; Frederick Struve; Linda S Williams; Aldo J Peixoto; Mark Gorman; Punit Goel; Gregory Acompora; Vincent McClain; Noshene Ranjbar; Paul B Tabereaux; John L Boice; Michael Jacewicz; John Concato
Journal:  Arch Intern Med       Date:  2010-05-10

2.  Diabetic myocardial infarction. Interaction of diabetes with other preinfarction risk factors.

Authors:  D E Singer; A W Moulton; D M Nathan
Journal:  Diabetes       Date:  1989-03       Impact factor: 9.461

3.  A multivariate analysis of the contribution of "auxometry" to prognosis in breast cancer.

Authors:  J L Pater; M Loeb; T O Siu
Journal:  J Chronic Dis       Date:  1979

4.  Chlamydia trachomatis and cervical neoplasia.

Authors:  J Schachter; E C Hill; E B King; D C Heilbron; R M Ray; A J Margolis; S A Greenwood
Journal:  JAMA       Date:  1982-11-05       Impact factor: 56.272

5.  Variation in antenatal testing over time and between clinic settings.

Authors:  J L Read; R S Stern; L A Thibodeau; D E Geer; H Klapholz
Journal:  JAMA       Date:  1983-03-25       Impact factor: 56.272

6.  Geographical, secular and ethnic influences in anencephalus.

Authors:  J M Elwood; G Mousseau
Journal:  J Chronic Dis       Date:  1978

7.  Chronic disease in former college students. XVII. Sociocultural mobility as a precursor of coronary heart disease and hypertension.

Authors:  R F Gillum; R S Paffenbarger
Journal:  Am J Epidemiol       Date:  1978-10       Impact factor: 4.897

8.  Maternal smoking during pregnancy and delinquency of the offspring: an association without causation?

Authors:  P Rantakallio; E Läärä; M Isohanni; I Moilanen
Journal:  Int J Epidemiol       Date:  1992-12       Impact factor: 7.196

9.  Association of induced abortion with subsequent pregnancy loss.

Authors:  A A Levin; S C Schoenbaum; R R Monson; P G Stubblefield; K J Ryan
Journal:  JAMA       Date:  1980-06-27       Impact factor: 56.272

10.  Seasonal variation in cause-specific mortality: are there high-risk groups? 25-year follow-up of civil servants from the first Whitehall study.

Authors:  C T van Rossum; M J Shipley; H Hemingway; D E Grobbee; J P Mackenbach; M G Marmot
Journal:  Int J Epidemiol       Date:  2001-10       Impact factor: 7.196

View more
  19 in total

1.  Association of Oral Anticoagulants and Proton Pump Inhibitor Cotherapy With Hospitalization for Upper Gastrointestinal Tract Bleeding.

Authors:  Wayne A Ray; Cecilia P Chung; Katherine T Murray; Walter E Smalley; James R Daugherty; William D Dupont; C Michael Stein
Journal:  JAMA       Date:  2018-12-04       Impact factor: 56.272

2.  Risk Factors for Late-Onset Group B Streptococcal Disease Before and After Implementation of Universal Screening and Intrapartum Antibiotic Prophylaxis.

Authors:  Jillian Pintye; Babette Saltzman; Elizabeth Wolf; Claudia S Crowell
Journal:  J Pediatric Infect Dis Soc       Date:  2015-10-12       Impact factor: 3.164

3.  Comparative Effectiveness and Safety of Direct Oral Anticoagulants: Overview of Systematic Reviews.

Authors:  Emanuel Raschi; Matteo Bianchin; Milo Gatti; Alessandro Squizzato; Fabrizio De Ponti
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

4.  Marginal Structural Models for Risk or Prevalence Ratios for a Point Exposure Using a Disease Risk Score.

Authors:  David B Richardson; Alexander P Keil; Alan C Kinlaw; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2019-05-01       Impact factor: 4.897

5.  The "Dry-Run" Analysis: A Method for Evaluating Risk Scores for Confounding Control.

Authors:  Richard Wyss; Ben B Hansen; Alan R Ellis; Joshua J Gagne; Rishi J Desai; Robert J Glynn; Til Stürmer
Journal:  Am J Epidemiol       Date:  2017-05-01       Impact factor: 4.897

6.  Reducing Bias Amplification in the Presence of Unmeasured Confounding Through Out-of-Sample Estimation Strategies for the Disease Risk Score.

Authors:  Richard Wyss; Mark Lunt; M Alan Brookhart; Robert J Glynn; Til Stürmer
Journal:  J Causal Inference       Date:  2014-09-01

7.  Standardizing Discrete-Time Hazard Ratios With a Disease Risk Score.

Authors:  David B Richardson; Alexander P Keil; Jessie K Edwards; Alan C Kinlaw; Stephen R Cole
Journal:  Am J Epidemiol       Date:  2020-10-01       Impact factor: 4.897

8.  Racial and ethnic disparities in coronavirus disease 2019 disease incidence independent of comorbidities, among people with HIV in the United States.

Authors:  Rachel A Bender Ignacio; Adrienne E Shapiro; Robin M Nance; Bridget M Whitney; Joseph A C Delaney; Laura Bamford; Darcy Wooten; Maile Y Karris; William C Mathews; Hyang Nina Kim; Jeanne Keruly; Greer Burkholder; Sonia Napravnik; Kenneth H Mayer; Jeffrey Jacobson; Michael Saag; Richard D Moore; Joseph J Eron; Amanda L Willig; Katerina A Christopoulos; Jeffrey Martin; Peter W Hunt; Heidi M Crane; Mari M Kitahata; Edward R Cachay
Journal:  AIDS       Date:  2022-05-06       Impact factor: 4.632

9.  Atypical antipsychotics olanzapine, quetiapine, and risperidone and risk of acute major cardiovascular events in young and middle-aged adults: a nationwide register-based cohort study in Denmark.

Authors:  Björn Pasternak; Henrik Svanström; Mattis F Ranthe; Mads Melbye; Anders Hviid
Journal:  CNS Drugs       Date:  2014-10       Impact factor: 5.749

10.  Optimal duration for continuation of statin therapy in bacteremic patients.

Authors:  Ajinkya M Pawar; Kerry L LaPlante; Tristan T Timbrook; Aisling R Caffrey
Journal:  Ther Adv Infect Dis       Date:  2018-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.